BrainEver
PrivateLast Round
Grant
Jun 8, 2022
Total Funding Raised
$27.53M
Company Overview
BrainEver is a biotechnology company that develops innovative therapies for neurodegenerative diseases using homeoprotein-based treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainEver Comparables
Compare BrainEver with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProJenX, Inc. | 80% | |
| AcuraStem | 78% | |
| Aclipse Therapeutics | 76% | |
BrainEver Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 8, 2022 | ||||
| Series A | Nov 23, 2020 |
Key People
Founding team and executive leadership
BrainEver Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Turenne Groupe | Series A |
| iBionext | Series A |
| Bpifrance | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 22, 2026
Grew 29% QoQ, from 21 to 27 employees.
- Jan 16, 2025
Grew 20% QoQ from 15 to 18 employees.
BrainEver Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BrainEver's valuation, stock price, and market status.